Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer.

D'Alincourt Salazar, Marcela; Manuel, Edwin R; Tsai, Weimin; D'Apuzzo, Massimo; Goldstein, Leanne; Blazar, Bruce R; Diamond, Don J

D'Alincourt Salazar, Marcela; Manuel, Edwin R; Tsai, Weimin; D'Apuzzo, Massimo; Goldstein, Leanne; Blazar, Bruce R; Diamond, Don J.

Afiliación

D'Alincourt Salazar M; Department of Experimental Therapeutics, Beckman Research Institute of City of Hope , Duarte, CA, USA.
Manuel ER; Department of Experimental Therapeutics, Beckman Research Institute of City of Hope , Duarte, CA, USA.
Tsai W; Department of Hematology/Hematopoietic Cell Transplantation, Beckman Research Institute of City of Hope , Duarte, CA, USA.
D'Apuzzo M; Department of Pathology, Beckman Research Institute of City of Hope , Duarte, CA, USA.
Goldstein L; Department of Information Sciences, Beckman Research Institute of City of Hope , Duarte, CA, USA.
Blazar BR; Department of Pediatrics, University of Minnesota , Minneapolis, MN, USA.
Diamond DJ; Department of Experimental Therapeutics, Beckman Research Institute of City of Hope , Duarte, CA, USA.

Oncoimmunology ; 5(6): e1160184, 2016 Jun.

Article en En | MEDLINE | ID: mdl-27471630

Palabras clave

Adaptive immunity; innate immunity; pancreatic ductal adenocarcinoma; programmed death receptor 1 (PD1); tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google